Literature DB >> 27918713

Gefitinib Plus Pemetrexed As First-Line Treatment in Patients With Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations.

Young Hak Kim1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27918713     DOI: 10.1200/JCO.2016.70.2472

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress.

Authors:  Chenyu Qiu; Tingting Zhang; Wenxin Zhang; Lina Zhou; Bin Yu; Wei Wang; Zhihong Yang; Zhiguo Liu; Peng Zou; Guang Liang
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.